Thrombin Generation in Patients With Suspected Venous Thromboembolism
Authors:
Open Access
- 24 March 2017
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 23 (5) , 416-421
Abstract
Increasing number of patients with clinically suspected venous thromboembolism is referred to radiological departments for definitive diagnosis. A simple assay to exclude the diagnosis and avoid radiological examinations is needed. We have reported correlations between D-dimer and prothrombin fragment 1 + 2 measured in plasma and urine. To further develop an analysis based on urine, more understanding of thrombin generation in these patients is needed. The aim of this study was to compare ex vivo thrombin generation with in vivo markers in plasma and urine in patients with and without venous thromboembolism. Urine and blood samples were collected from patients with suspected venous thromboembolism. Commercially available enzyme-linked immunosorbent assay (ELISA) kits were used to analyze the samples for in vivo thrombin generation. The ex vivo thrombogram parameters were measured by the calibrated automated thrombogram assay. Venous thromboembolism was verified with compression ultrasound of the lower extremity deep veins or with computer tomography of the pulmonary arteries. Venous thromboembolism was diagnosed in 117 of 591 patients, and they had significantly higher levels of urine and plasma prothromin fragment 1 + 2, D-dimer, lag time, time to peak, and endogenous thrombin potential when adjusted for covariates. The pattern of ex vivo and in vivo thrombin generation in patients with suspected venous thromboembolism was comparable when adjusted for covariates. Prothrombin fragment 1 + 2 in plasma and urine reflects thrombin generation ex vivo in the same manner. This indicates that urine may be an alternative substrate to quantify a procoagulant state.Keywords
This publication has 21 references indexed in Scilit:
- D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolismBlood Coagulation & Fibrinolysis, 2016
- Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolismThrombosis Research, 2014
- Thrombin split products (prothrombin fragment 1+2) in urine in patients with suspected deep vein thrombosis admitted for radiological verificationThrombosis Research, 2013
- Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) studyJournal of Thrombosis and Haemostasis, 2009
- Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrenceBritish Journal of Haematology, 2007
- The endogenous thrombin potential and the risk of venous thromboembolismThrombosis Research, 2007
- Diagnosing pulmonary embolism: running after the decreasing prevalence of cases among suspected patientsJournal of Thrombosis and Haemostasis, 2004
- The Calibrated Automated Thrombogram (CAT): a universal routine test for hyper- and hypocoagulabilityPathophysiology of Haemostasis and Thrombosis, 2002
- A prospective study of the incidence of deep‐vein thrombosis within a defined urban populationJournal of Internal Medicine, 1992
- A Population-Based Perspective of the Hospital Incidence and Case-Fatality Rates of Deep Vein Thrombosis and Pulmonary EmbolismArchives of internal medicine (1960), 1991